Cargando…

CD56 positive central nervous system plasmacytosis in a patient with refractory CD56 negative primary plasma cell leukaemia

Detalles Bibliográficos
Autores principales:	Yong, Jun, Schofield, Jeremy, Lawton, David, Brearton, Gillian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Haematology Images
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175821/ https://www.ncbi.nlm.nih.gov/pubmed/35845196 http://dx.doi.org/10.1002/jha2.271

Ejemplares similares

Central nervous system plasmablastic lymphoma evolving from polyclonal plasmacytosis
por: Khan, Umair T., et al.
Publicado: (2018)

Unusual CD34 positivity in acute myeloid leukaemia with myelodysplasia‐related changes with megakaryoblastic differentiation
por: Avenoso, Daniele, et al.
Publicado: (2021)

Plasmablastic myeloma progressed to plasma cell leukaemia
por: Xu, Ke, et al.
Publicado: (2021)

Primary plasma cell leukaemia presenting as unilateral proptosis
por: Schrijver, Irene T., et al.
Publicado: (2023)

Alterations in the CD56(−) and CD56(+) T Cell Subsets during COVID-19
por: Vavilova, Julia D., et al.
Publicado: (2023)

Atypical CD5 and CD10 coexpression in a splenic marginal zone lymphoma
por: Gimenez De Mestral, Santiago, et al.
Publicado: (2021)

Chronic myeloid leukaemia with marked thrombocytosis
por: Ooi, Jun, et al.
Publicado: (2020)

Helicobacter cinaedi bacteremia in a patient with primary central nervous system lymphoma
por: Fujita, Mai, et al.
Publicado: (2021)

IgG kappa multiple myeloma with isolated central nervous system relapse
por: Xu, Ke, et al.
Publicado: (2022)

Two ophthalmic presentations of chronic myeloid leukaemia
por: Kiernan, Miles, et al.
Publicado: (2022)

Burkitt leukaemia with B‐cell precursor immunophenotype
por: Xu, Ke, et al.
Publicado: (2022)

Central nervous system Langerhans cell histiocytosis and neurodegenerative syndrome responding to MEK inhibition
por: Wahba, Andrew, et al.
Publicado: (2021)

Transformation of myelodysplastic syndrome to mixed phenotype acute leukaemia
por: Do, Louis, et al.
Publicado: (2020)

Phlegmonous gastritis as the initial presentation of acute myeloid leukaemia
por: Lee, Shin, et al.
Publicado: (2022)

Megakaryoblasts in pleural fluid in neonate with transient leukaemia of Down's syndrome
por: Chmielowiec, Karolina, et al.
Publicado: (2023)

Roth spots and retinal haemorrhages as initial presentations of chronic myeloid leukaemia
por: Jacob, Nkemdirim, et al.
Publicado: (2021)

Acute myeloid leukaemia with aberrant expression of pancytokeratin: A diagnostic pitfall
por: Dhonye, Yasin, et al.
Publicado: (2022)

Development of JAK2 positive myelofibrosis on a background of chronic myeloid leukaemia
por: Mullen, Christopher Gerard, et al.
Publicado: (2022)

Cup‐like blasts in acute myeloid leukaemia with NPM1 and IDH2 mutations
por: Ohya, Eiko, et al.
Publicado: (2021)

Circulating promastocytes and atypical mast cells in systemic mastocytosis associated with acute myelogenous leukaemia transformation
por: Altohami, Mohammed O. A., et al.
Publicado: (2021)

To be or not to be: the role of CD56 in multiple myeloma
por: Cottini, Francesca, et al.
Publicado: (2023)

Ocular toxoplasmosis during frontline venetoclax therapy for chronic lymphocytic leukaemia – more than meets the eye
por: Bennett, Rory, et al.
Publicado: (2023)

The DC-SIGN-CD56 interaction inhibits the anti-dendritic cell cytotoxicity of CD56 expressing cells
por: Nabatov, Alexey A., et al.
Publicado: (2015)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Mixed‐phenotype acute leukemia consisting of five heterogeneous leukemic populations without the expression of CD34
por: Nishino, Takahiro, et al.
Publicado: (2020)

Whole body‐diffusion weighted imaging for the assessment of treatment response in hairy cell leukaemia: A positive first step
por: Algudkar, Ashwin, et al.
Publicado: (2021)

Lymphocyte morphology in a patient receiving CD19 chimeric antigen receptor T‐cell therapy for mantle cell lymphoma
por: Marzolini, Maria A. V., et al.
Publicado: (2021)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

Efficacy and safety of humanized anti‐CD19‐CAR‐T therapy following intensive lymphodepleting chemotherapy for refractory/relapsed B acute lymphoblastic leukaemia
por: Wang, Jia, et al.
Publicado: (2020)

Chronic Myeloid Leukaemia with isolated massive thrombocytosis and BCR‐ABL1 detection failure using RT‐MLPA (positive RT‐qPCR)
por: Coster, Lucie, et al.
Publicado: (2021)

Ibrutinib response in a patient with refractory mixed essential cryoglobulinemia
por: Jamali, Haya, et al.
Publicado: (2023)

Ublituximab (TG‐1101), a novel glycoengineered anti‐CD20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial
por: Sharman, Jeff P., et al.
Publicado: (2016)

CD56 Expression in Odontogenic Cysts and Tumors
por: Jaafari-Ashkavandi, Zohreh, et al.
Publicado: (2014)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

NK cells CD56(bright) and CD56(dim) subset cytokine loss and exhaustion is associated with impaired survival in myeloma
por: Seymour, Frances, et al.
Publicado: (2022)

Diagnostic Challenges of CD4(+)/CD56(+)/CD123(+) hematological neoplasms
por: Thiago, Leandro S., et al.
Publicado: (2013)

T‐helper cell regulation of CD45 phosphatase activity by galectin‐1 and CD43 governs chronic lymphocytic leukaemia proliferation
por: Imbery, John F., et al.
Publicado: (2022)

CD56(dim)CD16(high) and CD56(bright)CD16(−) cell percentages associated with maximum knee extensor strength and incidence of death in elderly
por: Senpuku, Hidenobu, et al.
Publicado: (2016)

Giant multinucleated plasma cells in relapsed plasma cell myeloma
por: Ghattas, Sylvia, et al.
Publicado: (2020)

MRI findings of nelarabine‐related rhabdomyolysis in a patient with refractory T‐cell acute lymphoblastic leukemia
por: Mukai, Daiki, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_canb78pohjqhlpihhjq76n81q6